The mental health industry is the only sector that can watch its product fail at scale and use the failure as evidence of demand.
U.S. suicide rates have risen approximately 30% since 2000. Almost a third of American adults now report symptoms of depression or anxiety — roughly three times as many as in 2019. The share of adults rating their mental health as excellent has fallen from 43% to 31% over two decades. These numbers did not arrive in a therapeutic vacuum. They arrived alongside the most significant expansion of therapy participation in American history. The response from the mental health establishment has been consistent: we need more therapy. This is not a scientific conclusion. It is a market position.
Start with what the field knows about itself and declines to say clearly. Approximately 10% of therapy clients get measurably worse after beginning treatment. A 2016 survey led by the Royal College of Psychiatrists found that 1 in 20 people reported lasting bad effects — with minority-ethnic and LGBTQ+ individuals disproportionately represented among those harmed. Two recent systematic reviews found a general failure to report adverse effects across the field, and no consistent definition of what an adverse effect even is. The clinical instrument designed to measure negative outcomes explicitly lists therapy dependency and treatment prolongation as recognized harms. The field has named the problem. It has then declined to report it, systematically, in its published literature.
Apply the standard that governs every other medical intervention. A pharmaceutical compound with a 10% documented deterioration rate, no standardized harm-reporting mechanism, and a publication record structured to suppress negative results would not reach the market. It would be pulled from trials. That therapy operates under no equivalent obligation — while lobbying successfully for insurance parity with medical treatment — is not an oversight. It is a choice the industry has made about its own accountability, and that regulators have allowed.
The individual bad therapist is not the primary problem, though psychotoxic practitioners who undermine confidence and foster dependency are real and documented. The deeper problem is structural, and it operates at two levels simultaneously.
The first is economic. A therapy model built on open-ended weekly sessions with no defined endpoint and no outcome measurement creates incentives precisely misaligned with cure. The therapist who resolves a problem quickly loses income. The one who helps a client develop a rich interpretive language for their suffering — who makes the suffering feel meaningful, navigable, worth returning to examine — retains a patient. This is not a conspiracy. It is what markets do when you do not measure what matters. The result is an industry optimized for retention, billing it as care.
The second level is philosophical, and it is the one the industry cannot afford to examine. Individual therapy, by its architecture, locates suffering inside the individual psyche. The question it is structurally capable of asking is: what is wrong with you, and how can you be adjusted? The questions it cannot ask — because they have no billable answer — are: what is wrong with the conditions under which you live, and who benefits from your adjustment to them? This is not a neutral omission. It is a political act performed in the language of medicine.
Group interventions for at-risk youth — the Cambridge-Somerville Study, the Adolescent Transition Programme, DARE — have in documented cases made behavior worse, partly by concentrating vulnerable individuals and normalizing dysfunction among them. The social dimension of suffering can amplify harm when handled badly. Yet the dominant cultural response to the mental health crisis is to push people further into the individual therapeutic dyad — further into the room where suffering is refined, interpreted, and managed, rather than into the social structures that might actually address it.
Meanwhile, the vocabulary has escaped. Gaslighting, toxic, boundaries, trauma — these words have moved from the clinic into ordinary social life and are doing something specific there. They are teaching people to read ordinary human friction as pathology, to treat the difficult person as a threat to be excised rather than a relationship to be navigated. The therapy model's emphasis on personal boundaries may be in direct conflict with our evolutionary wiring for group belonging and interdependence. Isolation is a primary driver of psychological deterioration. The therapeutic culture is, in significant measure, producing and then treating the same condition.
A man named Shorty, seeking help for substance abuse, described his experience plainly: "We just talked, but we weren't really solving anything. I was just paying this dude money." He is not a data point. He is the person at the end of the logic.
The proposition is not that therapy never helps anyone. It is that an industry which demonstrably worsens outcomes for a significant fraction of its clients, suppresses its own adverse-event data, faces no mandatory informed-consent requirement about documented risks, and structurally redirects collective suffering into individual management has no business presenting itself as a public health solution. What it is, instead, is the thing that failing societies build when they have decided not to address what is actually wrong.